PCN10 A MATCH-ADJUSTED INDIRECT TREATMENT COMPARISON (MAIC) OF LENALIDOMIDE PLUS RITUXIMAB (R2) VERSUS RITUXIMAB PLUS CHEMOTHERAPY (R-CHEMO) FOR RELAPSED AND/OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.207
https://www.valueinhealthjournal.com/article/S1098-3015(19)32585-9/fulltext
Title :
PCN10 A MATCH-ADJUSTED INDIRECT TREATMENT COMPARISON (MAIC) OF LENALIDOMIDE PLUS RITUXIMAB (R2) VERSUS RITUXIMAB PLUS CHEMOTHERAPY (R-CHEMO) FOR RELAPSED AND/OR REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32585-9&doi=10.1016/j.jval.2019.09.207
First page :
Section Title :
Open access? :
No
Section Order :
10152